Albireo Pharma Inc (NASDAQ:ALBO)

34.53
Delayed Data
As of Feb 16
 -1.06 / -2.98%
Today’s Change
15.31
Today|||52-Week Range
39.87
+34.88%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues0.000.000.0011.4M
 
 
Depreciation And Amortization641.0K603.0K197.0K14.0K
 
 
 
 
 
 
Operating ExpensesGross Income---603.0K-197.0K11.4M
 
 
 
 
General Expenses20.5M19.2M19.6M18.2M
 
 
 
 
 
Other Operating Expenses0.000.000.00503.8M
 
 
Research And Development14.3M14.2M13.4M8.1M
 
 
 
 
 
Total Operating Expenses21.1M19.8M19.8M522.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-21.1M-19.8M-19.8M-510.7M
 
 
 
 
 
Extraordinary Credit1.2M5.1M1.0M504.0M
 
 
 
 
 
Extraordinary Charge0.000.000.00-5.6M
 
 
Interest Expense On Debt0.000.000.001.3M
 
 
Other Expenses546.0K531.0K-2.0K-2.6M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-19.3M-14.1M-18.7M-16.3M
 
 
 
 
 
Income Taxes-15.0K-26.0K-29.0K-62.0K
 
 
 
 
 
Net Income-19.3M-14.1M-18.7M-16.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS521.7K713.5K1.4M1.2M
 
 
 
 
 
Shares To Calculate EPS Diluted521.7K713.5K1.4M1.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$37.20-$19.80-$13.80-$13.19
 
 
 
 
 
EPS Diluted-$37.20-$19.80-$13.80-$13.19